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Abstract
Background: Ciliary neurotrophic factor (CNTF), a member of the interleukin-6 cytokine family, has been implicated in the
development, differentiation and survival of retinal neurons. The mechanisms of CNTF action as well as its cellular targets in
the retina are poorly understood. It has been postulated that some of the biological effects of CNTF are mediated through
its action via retinal glial cells; however, molecular changes in retinal glia induced by CNTF have not been elucidated. We
have, therefore, examined gene expression dynamics of purified Mu ¨ller (glial) cells exposed to CNTF in vivo.
Methodology/Principal Findings: Mu ¨ller cells were flow-sorted from mgfap-egfp transgenic mice one or three days after
intravitreal injection of CNTF. Microarray analysis using RNA from purified Mu ¨ller cells showed differential expression of
almost 1,000 transcripts with two- to seventeen-fold change in response to CNTF. A comparison of transcriptional profiles
from Mu ¨ller cells at one or three days after CNTF treatment showed an increase in the number of transcribed genes as well
as a change in the expression pattern. Ingenuity Pathway Analysis showed that the differentially regulated genes belong to
distinct functional types such as cytokines, growth factors, G-protein coupled receptors, transporters and ion channels.
Interestingly, many genes induced by CNTF were also highly expressed in reactive Mu ¨ller cells from mice with inherited or
experimentally induced retinal degeneration. Further analysis of gene profiles revealed 20–30% overlap in the transcription
pattern among Mu ¨ller cells, astrocytes and the RPE.
Conclusions/Significance: Our studies provide novel molecular insights into biological functions of Mu ¨ller glial cells in
mediating cytokine response. We suggest that CNTF remodels the gene expression profile of Mu ¨ller cells leading to
induction of networks associated with transcription, cell cycle regulation and inflammatory response. CNTF also appears to
function as an inducer of gliosis in the retina.
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Introduction
Cytokines are secretory proteins that were initially characterized
as immune modulators, but have been subsequently found to
promote proliferation and differentiation in the nervous system [1].
The cytokine, ciliary neurotrophic factor (CNTF: NM_170786.2),
belongs to the interleukin 6 (IL-6: NM_031168.1) family of
cytokines that share one or more of the receptor subunit,
glycoprotein 130 (gp130: NM_010560.3) [2,3]. Activation by
CNTF requires a heterotrimeric complex consisting of CNTF
receptor a (CNTFRa: NM_001136056.2), leukemia inhibitory
factor b (LIFRb: NM_001113386.1) receptor and gp130 [2,3].
CNTF acts on cells primarily by stimulating the Janus kinase-
signal transducer and activator of transcription (JAK-STAT)
signaling pathway [3]. Additionally, CNTF may stimulate cell
survival, through MEK [extracellular signal-regulated kinase
(ERK) kinase]/MAPK (mitogen activated protein kinase),
Phosphoinositide 3-kinase (PI3-K)/Akt, and Nuclear factor kB
(NF-kB) pathways [4–12].
CNTF promotes the survival of a variety of neurons and
oligodendrocytes, and induces neurite outgrowth and axon
regeneration in both developing and mature nervous system
[13–18]. In addition, it appears to be an effective neuroprotective
agent in animal models of CNS neurodegenerative diseases [19].
CNTF has also been reported to activate leptin-like pathways in
the brain and reduce body fat and stress in a leptin-independent
manner [20].
In the vertebrate retina, CNTF exhibits numerous effects on the
development, differentiation and survival of retinal neurons [21].
CNTF appears to play a critical role in progenitor commitment to
the rod photoreceptor cell fate and in photoreceptor differentiation
[22–24]. It is reported to increase the long-term survival of retinal
ganglion cells after axotomy [25,26]. Furthermore, CNTF is
capable of retarding retinal degeneration in several animal models
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effective and mutation-independent, neuroprotective agent
known. A recent phase I clinical trial demonstrated the safety of
chronic CNTF delivery in patients with retinitis pigmentosa [37],
and phase II trials have been completed for patients with retinitis
pigmentosa (RP) and age-related macular degeneration (AMD).
Molecular mechanisms proposed to explain the neuroprotective
role of CNTF in the retina include (i) direct action on
photoreceptors to prevent their apoptosis (ii) stimulation of Mu ¨ller
(glial) cells to produce photoreceptor survival factors [38] (iii)
enhanced synthesis or distribution of glutamate transporters,
thereby improving glutamate handling, resulting in less excitotoxic
damage to retinal neurons [39] and (iv) induction of metabolic
plasticity and increased resistance to metabolic damage [40].
Nevertheless, these mechanisms remain to be evaluated.
A primary target of CNTF action in the retina is the Mu ¨ller cell,
a predominant glial cell that is responsible for maintaining the
health and activity of retinal neurons [41,42]. Mu ¨ller cells contain
CNTF receptors [19], and the JAK-STAT signaling pathway is
rapidly activated in Mu ¨ller cells in response to intravitreal CNTF
injection [43–46]. Many of the biological effects of CNTF are
proposed to be mediated through Mu ¨ller cells [38]. Here, we have
determined the global transcriptional response of Mu ¨ller cells to
CNTF in vivo with a goal to elucidate the molecular basis of its
biological actions in the retina.
Results
Purification of Mu ¨ller cells by flow-sorting
Mu ¨ller (glial) cells constitute ,2% of the cells in the mouse
retina [47]. A major hurdle in studying CNTF action on Mu ¨ller
cells has been the lack of a reliable method to separate these cells
away from retinal neurons. To circumvent this problem, we
recently used Fluorescence Activated Cell Sorter (FACS) to purify
Mu ¨ller cells from mgfap-egfp (mouseGlial fibrillary acidic protein
(NM_001131020.1)-enhanced green fluorescent protein) transgen-
ic mice in which only Mu ¨ller cells express GFP [48] (Fig. 1A).
Retinas were dissociated into a single cell suspension following
treatment with papain, and GFP
+ (Mu ¨ller) cells were enriched by
FACS (Fig. 1B–D). During dissociation, Mu ¨ller cells lose their
radial processes and round up, but GFP remaining in the cell body
is sufficient for flow sorting. We routinely obtained 30–50,000
viable cells per mouse retina. For microarray studies, we pooled
retinas from 4–6 mice in each independent sample.
Transcriptional analysis of Mu ¨ller cells
To study the transcriptional response of Mu ¨ller cells to CNTF,
mgfap-egfp transgenic mice were intravitreally injected with CNTF
or PBS (control). One day later, GFP
+-Mu ¨ller cells were flow-
sorted, and total RNA was prepared for microarray analysis [49].
CNTF treatment resulted in differential expression of 923
transcripts that showed at least two-fold change (P-value ,0.05).
Of these, 691 transcripts exhibited 2-to 17-fold higher expression,
whereas 232 transcripts revealed 2-to 5-fold reduction. We
noticed, however, that genes such as gfap that are known to be
induced by CNTF, were not detected. When the microarray data
were analyzed with P-value,0.1, however, we found several genes
of biological interest among 1261 differentially expressed tran-
scripts. Of these, 939 transcripts were elevated 2- to 17-fold, and
322 transcripts were depressed 2- to 5-fold. The differentially
expressed genes fell into several functional types (Table 1). A
complete list of differentially regulated genes is presented in Table
S1. A hierarchical cluster analysis also showed that genes with
increased expression level outnumbered genes with decreased
level, and that CNTF-induced genes fell into several clusters of co-
expressed genes (Figure 2).
Validation of transcript level changes
Real time-PCR (qPCR) analysis of independent samples of
FACS-purified Mu ¨ller cells was carried out to validate the findings
from the microarray data [23]. We performed primer design, one-
step RT-PCR reaction, and qPCR analysis as previously described
[49]. To determine the relative change in gene expression, we used
the system software to compare the number of cycles (Ct) needed to
reach the midpoint of the linear phase. All observations were
normalized to the housekeeping gene Gapdh (NM_008084.2). We
observed that amongthe15 transcripts (fromdifferent gene families)
tested, 12 genes demonstrated higher transcript levels, consistent
with the microarray data (Figure 3). Two transcripts (NUD6:
NM_008006.2, CKLF: NM_029295.2) showed a negative trend in
the qPCR assay (Figure 3), whereas one transcript (MAPK8:
NM_016700.4) that exhibited reduced expression in the microarray
data also showed a downward trend in the qPCR analysis. These
results establish that transcript changes observed in the microarray
data represent the gene expression changes in Mu ¨ller cells.
Pathways and biological processes associated with CNTF
Computational approaches were employed to identify biological
pathways among the list of differentially expressed genes that
Figure 1. Flow-sorting Mu ¨ller cells from mouse retina. (a) Transverse section of retina from mgfap-egfp transgenic mice. Note GFP expression
in radially-oriented, Mu ¨ller cell processes. (b–c) Scatter plot of flow-sorted, dissociated cells from mgfap-egfp transgenic mouse retina. The cells used
for RNA preparation were collected from the enclosed area in F indicated by the arrow. Dissociated cells from non-transgenic mouse retina showed
no GFP-fluorescence.
doi:10.1371/journal.pone.0020326.g001
CNTF Effects on Retinal Mu ¨ller (Glia) Cells
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one day after CNTF treatment.
Gene
Symbol Gene Name
Fold
Change Type
Ccl6 Chemokine ligand 6 13.5 Cytokine
(19, 1)
Ccl5 Chemokine ligand 6 13.3 -
Spp1 Secreted phosphoprotein 1 10 -
Tnf Tumor necrosis factor 7.8 -
Il1rn Interleukin 1 receptor antagonist 7.5 -
Av3 Vav 3 guanine nucleotide exchange
factor
-2.2 -
Hmox1 Heme oxygenase 15.9 Enzyme
(115, 32)
Iigp1 Interferon inducible GTPase 1 8.8 -
Ptgs2 Prostaglandin-endoperoxide
synthase 2
10.3 -
Oasl 29-59-oligoadenylate synthetase-like 6.9 -
XDH Xanthine dehydrogenase 6.6 -
Pafah1b1 Platelet-activating factor
acetylhydrolase 1b
-2.5 -
Rab2b RAB2B, member RAS oncogene family -2.5 -
Rab3c RAB3C, member RAS oncogene family -2.5 -
Rims1 Regulating synaptic membrane
exocytosis 1
-2.6 -
Scd2 Stearoyl-Coenzyme A desaturase 2 -2.6 -
Ccrl2 Chemokine (C-C motif) receptor-like 2 12.5 G-protein
(16, 9)
Gpr109a G protein-coupled receptor 109A 9.4 -
Ccr1 Chemokine (C-C motif) receptor 1 8.9 -
C5ar1 Complement component 5a
receptor 1
7.7 -
Emr1 Egf-like module, mucin-like
chemokine-like recp 1
7.0 -
Tm2d1 TM2 domain containing 1 -2.0 -
Xpr1 Xenotropic and polytropic retrovirus
receptor 1
-2.2 -
Ptger3 Prostaglandin E receptor 3
(subtype EP3)
-2.7 -
Lphn3 Latrophilin 3 -2.7 -
Gpr158 G protein-coupled receptor 158 -2.9 -
Edn2 Endothelin 2 6.7 Growth
Factor (8, 2)
Gmfg Glia maturation factor, gamma 5.3 -
Nudt6 Nudix-type motif 6 4.2 -
Tgfb1 Transforming growth factor, beta 1 3.8 -
Gmfg Glia maturation factor, gamma 3.4 -
Angpt1 Angiopoietin 1 -2 -
Fgf9 Fibroblast growth factor 9
(glia-activating factor)
-2 -
Kcnk6 Potassium channel, subfamily K,
member 6
4.5 Ion Channel
(7, 11)
P2rx7 Purinergic receptor P2X,
ligand-gated ion cha, 7
3.9 -
Kctd12 Potassium channel tetramerisation
domain
3.2 -
Table 1. Cont.
Gene
Symbol Gene Name
Fold
Change Type
Kcnn4 Potassium intermediate/small
calcium-activated
2.7 -
Hvcn1 Hydrogen voltage-gated channel 1 2.4 -
Kcnj6 Potassium inwardly-rectifying channel -2.3 -
Kcnip1 Kv channel interacting protein 1 -2.4 -
Scn2b Sodium channel, voltage-gated,
type II, beta
-2.4 -
Kcnma1 Potassium large conductance
calcium-activated
-2.7 -
Stx1b Syntaxin 1B -3.1 -
Vav1 Vav 1 guanine nucleotide exchange
factor
9.7 Transc.
Regulator
(78, 28)
Egr2 Early growth response 2 8.5 -
Atf3 Activating transcription factor 3 7.5 -
Klf4 Kruppel-like factor 4 (gut) 7.4 -
Ifi16 Interferon, gamma-inducible
protein 16
7.3 -
Ldb2 LIM domain binding 2 -3.3 -
Nfib Nuclear factor I/B -3.3 -
Nfia Nuclear factor I/A -3.0 -
Ccnt2 Cyclin T2 -2.9 -
Pcgf6 Polycomb group ring finger 6 -2.5 -
Cd14 CD14 molecule 9.3 Transm.
Receptor
(50, 3)
Il7r Interleukin 7 receptor 8.9 -
Msr1 Macrophage scavenger receptor 1 8.3 -
Tlr2 Toll-like receptor 2 8.0 -
Cd69 CD69 molecule 7.9 -
Cd247 CD247 molecule -2.6 -
Gpc6 Glypican 6 -2.5 -
Ifnar1 Interferon (alpha, beta and omega)
receptor 1
-2.1 -
Slc11a1 Solute carrier family 11 7.3 Transporters
(33,15)
Slc15a3 Solute carrier family 15, member 3 5.6 -
Slc3a3 Solute carrier family 13 5.6 -
Tap1 Transporter 1, ATP-binding
cassette, sub-family B
5.4 -
Mcl1 Myeloid cell leukemia
sequence 1 (BCL2-related)
5.2 -
Atp6v1b2 ATPase, H+ transporting,
lysosomal 56/58kDa
-2.7 -
Sec62 SEC62 homolog -2.7 -
Rph3a Rabphilin 3A homolog -2.6 -
Vps41 Vacuolar protein sorting 41 homolog -2.5 -
Slc6a1 Solute carrier family 6, member 1 -2.5 -
The table lists the top-five up- and down-regulated genes derived from IPA
analysis. The total number of up- and down–regulated genes in each type are
listed along with the functional types, in column 4.
doi:10.1371/journal.pone.0020326.t001
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(IPA) program (Ingenuity Systems, Red Wood City, CA), which
sorts genes into canonical pathways based on the scientific
literature and indicates significantly overrepresented pathways
[www.ingenuity.com] (Figure 2). The top canonical pathways were
concerned with the role of pattern recognition receptors,
production of reactive oxygen species, IL10 signaling and role of
macrophages in immune disease, consistent with the known roles
of IL-6 family of cytokines (Table 2). The top biological functions
were cellular development, cell death and cell- to -cell signaling
(Fig. 2), which are related to immune response, immunological
disease and inflammatory disease.
Genes induced by CNTF
Cytokines represented one of the highly induced sets of genes in
Mu ¨ller cells after exposure to CNTF (Table 1,S1). Furthermore,
many cytokines types including interleukins, chemokines and
chemokine-like factors, tumor necrosis factor and colony stimulat-
ing factor were elevated 2 to 14-fold. Among chemokines, both C-C
and CXC family members were detected. Intriguingly, multiple
proinflammatory chemokines were induced. Several enzymes
involved in intermediary, nucleic acid and lipid metabolism were
also elevated. Heme oxygenase-1 (NM_010442.2) was induced
at a high level, pointing to a role for CNTF in neuroprotection
against oxidative damage. Interestingly, transcript levels for
several chemokine receptors, CCRL2 (NM_017466.4), CCR1
(NM_009912.4), CXCR4 (NM_009911.3) and CCR5 (NM_009-
917.5) were increased in CNTF-treated Mu ¨ller cells. The induction
of chemokines and chemokine receptors suggests existence of
paracrine loops that could further modify CNTF-induced gene
expression pattern.
The well-known growth factor and anti-inflammatory agent,
transforming growth factor ß (TGFß: NM_011577.1) was induced
by CNTF. Expression of both TGFß and proinflammatory
chemokines suggests that CNTF has complex effects on Mu ¨ller
cells. Surprisingly, endothelin 2 (NM_007902.2), a signaling
molecule released by degenerating photoreceptors that initiates
Mu ¨ller cell gliosis [50], was strongly induced by CNTF; however,
no change in endothelin receptor B (endrB: NM_001136061.1)
expression was detected.
There were substantial changes in the expression of ion
channels including the potassium channels, KCNK6 (NM_0010-
33525.3) and KCNN4 (NM_001163510.1). We did not, however,
detect transcript level changes for two potassium channels, Kir4.1
(NM_001039484.1) and Kir2.1 (NM_008425.4), which are known
to be involved in potassium ion-homeostasis in Mu ¨ller cells [42].
As CNTF treatment induces a large number of genes, it was not
surprising that several transcriptional regulators such as CCAAT/
enhancer binding proteins, early growth response proteins, and
forkhead box proteins were elevated. In comparison, far fewer
translational regulators were altered.
We also identified higher expression of several transmembrane
receptors including cell adhesion molecules such as CD14
(NM_009841.3) and CD86 (NM_019388.3) although there was
no change in CD44 (NM_009851.2), a hyaluronic acid receptor,
expressed in Mu ¨ller cells [41]. In addition, a large number of
interleukin receptors were induced, suggesting the existence of
feed back loops in CNTF-induced networks. Expression of
Toll-like receptors 1 and 2 (TLR1: NM_030682.1 and TLR2:
NM_011905.3) was increased following CNTF treatment (Table
S1, Figure 3), suggesting that Mu ¨ller cells are part of the innate
immune response in the retina. One of the roles of Mu ¨ller cells
involves transport and export of nutrients and related small
molecules in the retina [41,4]. Induction of genes for a variety of
transporters belonging to ABC and SLC superfamilies is in accord
with the metabolic functions of Mu ¨ller cells [41]. Interestingly,
SLC11A1 (NM_013612.2) has been proposed as an autoimmunity
susceptibility gene.
Figure 2. Microarray data analysis. (a) Hierarchical clustering showing 1261 probes that have a P-val #0.1 and a minimum 2-fold change
between the CNTF and PBS samples at Day 1. Bright blue indicates lowest signal with increasing values indicated by yellow shading to bright red,
representing peak signal. (b) Most significant 10 canonical pathways corresponding to Day 1. (c) Most significant biological functions for the same list
of genes. (d) Hierarchical clustering showing 1541 probes that have a P-val #0.1 and a minimum 2-fold change between the CNTF and PBS samples
at Day 3. (e) Most significant 10 canonical pathways corresponding to Day 3. (f) Most significant biological functions for the same list of genes.
doi:10.1371/journal.pone.0020326.g002
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PLoS ONE | www.plosone.org 4 May 2011 | Volume 6 | Issue 5 | e20326Figure 3. qRT-PCR validation of selected genes using independent biological samples. Predicted fold changes from microarray analysis
and relative gene expression fold change from qRT-PCR for 3–6 independent biological replicates of flow-sorted Mu ¨ller cells. Error bars indicate
6SEM.
doi:10.1371/journal.pone.0020326.g003
Table 2. Canonical Pathway analysis of CNTF-induced genes at Day 1 and Day 3.
Canonical Pathways- Day 1 CNTF–associated genes p-value
Role of Pattern Recognition
Receptors of Bacteria and
Viruses
Tlr1, Pik3r5, Oas1b, Ccl5, C1qb, Ifih1, C5ar1, Ticam1, Pik3cg, Creb1, Tlr7, Casp1, Oas1, C3, Nlrp3, Oas2,
Nfkb2, Oas3 (includes EG:4940), Tlr2, Irf7, Clec7a, Syk, Ddx58, Tlr6, Pik3r6, Pik3cd, Elf2ak2, C3ar1, Tnf
9.59E
Dendritic Cell Maturation B2m, Rac2, Il1a, Icam1, Nfkbie, Pik3r5, Hla-drb1, Hla-dmb, Fcgr2b, Fcgr1a, Col1a2, Nfkbia, Pik3cg, Creb1,
Hla-b, Stat1, Tnfrsf1b, Fcgr3a, Hla-c, Tyrobp, Tnfrsf1a, Fcgr2a, Mapk8, Ikbke, Nfkb2, Tlr2, Col5a3, Il1rn,
Pik3r6, Fcer1g, Cd86, Pik3cd, Irf8, Tnf, Ifnar1
3.06E
Production of Nitric Oxide and
Reactive Oxygen Species in
Macrophages
Rap1b, Rac2, Nfkbie, Pik3r5, Rhoh, Ppp1r14b, Spii1, Map3k10, Rhog, Nfkbia, Pik3cg, Cyba, Ppm1l, Cybb,
Stat1, Tnfrsf1b, Map3k2, Ptpn6, Tnfrsf1A, Mapk8, Ikbke, Nfkb2, Ncf4, Irf1, Tlr2, Prkcd, Plcg2, Ncf2, Pik3r6,
Map3k8, Pik3cd, Irf8, Jak3, Tnf
1.93E
IL-10 Signaling Ccr1, Il18rap, Socs3, Ccr5, Il4r, Il1a, Il1rl1, Fcgr2a, Nfkbie, Mapk8, Ikbke, Nfkb2, Stat3, Fcgr2b, Il1r2, Hmox1,
Nfkb, Il1rn, Il10ra, Il10rb, Cd14, Tnf
4.67E
Role of Macrophages, Fibroblasts
and Endothelial Cells in
Rheumatiod Arthritis
Il18rap, Rac2, Socs3, Tlr1, Fcgr1a, Il1r2, Tgfb1, Pik3cg, Osm, Wnt5b, Tnfsf13b, C1s, Il6r, Stat3, Apc, Tlr2, Il1rn,
Cebpd, Plcg2, Prkcd, Pik3r6, Pik3cd, Tnf, Il1a, Fn1, Icam1, Il1rl1, Nfkbie, Pik3r5, Ccl5, Il17ra, C1r, Nfkbia, C5ar1,
Ppp3cb, Creb1, Tlr7, Cebpa, Tnfrsf1b, Fcgr3a, Traf1, Tnfrsf1a, Ikbke, Cebpb, Irak3, Ripk1, Csf1, Tlr6, Tlr13
6.21E
Canonical Pathways- Day 3 CNTF–associated genes p-value
Protein Ubiquitination Pathway Usp14, Psmd7, Psma7, Ube2l3, Ube2v2, Dnajc10, Psmb8, Hspa5, Psmc5, Usp48, Uchl1, Uso1, Dnajc28,
Hsp90b1, Hsp90ab1, Psmd10, Uchl5, Psmd14, Psma2, Psmc2, Birc3, Hspa4l, Hla-c, Psmb4, Psmb9, Psma6,
Hsph1, Usp9x, Psmd6, Psma1, Dnajb9, Psmd8, Psmb7, Psmc1, Cul2, Psmb2, Psmd12, Hspa13, Psmb1,
Dnajc5b, Smurf2, Uba1, Usp25, Dnajc7, Tceb1
3.8E-08
TREM 1 Signaling Itgb1, Rac2, Tyrobp, Tlr8 (includes EG:51311), Cd83, Jak2, Stat3, Fcgr2b, Tlr4, Ccl2, Plcg2, Tlr6, Casp1,
Tlr7, Cd86, Tlr13, Il1b, Itgax
5.48E-08
Fcg Receptor-mediated Phagocytosis
in Macrophages and Monocytes
Actr2, Rac2, Gab2, Fcgr2a, Actb, Arpc5, Fcgr1a, Inpp5d, Pld4, Myo5a, Hmox1, Rab11b, Pik3cg, Prkcd,
Syk, Arpc4, Vamp3, Lyn, Rab11a, Arpc3, Vav1, Fcgr3a, Lcp2, Prkcb
6.07E-08
N-Glycan Degradation Chi3l4, Fuca2, Edem1, Gm2a, Man1a1, Hexb, Lct, Hexa, Man2b1, Man2a1, Chi3l3 4.99E-06
CTLA4 Signaling in Cytotoxic T
Lymphocyte
Hla-dma, Ap2b1, Rac2, Ptpn6, Ppp2r2a, Ap1s2, Cltc, Hla-dqa11, Hla-drb1, Jak2, Hla-dqb1, Ppp2r1a,
Syk, Pik3cg, Clta, Fcer1g, Cd86, Pik3cb, Lcp2, Ap1g1
9.22E-06
The top-five pathways and associated genes are presented.
doi:10.1371/journal.pone.0020326.t002
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levels (Table 1, S1), with most showing a modest change of about
two-fold.
Long-time effects of CNTF
Cytokines are known for their rapid and transient action [1]. To
examine whether transcripts induced initially by CNTF continue
to be expressed or the gene expression pattern is further altered,
we investigated transcriptional changes in Mu ¨ller cells three days
following CNTF treatment. The biological activity of CNTF
appears to last 2–3 days, due perhaps both to degradation of the
cytokine [43] and activation of suppressor of cytokine signaling
systems [51]. We found that 1192 transcripts were increased 2- to
26-fold, and 349 transcripts were reduced 2- to 10-fold. (Table 3;
see Table S2 for a complete list). A comparison of transcriptome
data from Mu ¨ller cells at one and three days after CNTF exposure
showed that (i) there is an increase in the number of genes
transcribed from 1261 to 1541; and (ii) the pattern of transcribed
genes is changed, only 273 overlapping transcripts were detected
at these two time-points.
IPA analysis was used to categorize genes according to
canonical pathways and functions (Table 2). At day 3, the
networks involved in CNTF signaling had changed and new
canonical pathways and functional groups were operative
(Figure 4). The top canonical pathways were now associated with
protein ubiquitination, TREM1 signaling and receptor mediated
phagocytosis. The molecular and cellular functions involved cell
death, and cell growth and proliferation (Table 2). These network
changes are likely to represent the altered role of Mu ¨ller cells in
CNTF signaling in the retina.
cThe differentially regulated transcripts could be classified into
distinct functional types using IPA (Table 3). At three days, we
found the induction of chemokine, CCl2 (NM_011333.3), which is
known to be involved in the activation and chemoattraction of
circulating macrophages into tissues [52]. Relatively few growth
factors were induced at day three unlike at day one. We also
observed a high induction of the glycoprotein, GPNMB
(NM_053110.4), a melanosome-associated protein implicated in
cancer metastasis [53]. The chemokine receptor, CCR5, contin-
ued to be expressed at 3 days. In support of the continuing role
of Mu ¨ller cells in innate immunity, we found a 14-fold incre-
ase in TLR13 (NM_205820.1) and 7-fold increase in TLR7
(NM_133211.3) levels in Mu ¨ller cells.
Networks induced by CNTF
Next, we examined network(s) that contained genes relevant to
CNTF action. Several networks were generated using Metacore
(www.genego.com/metacore.php), and genes associated with one
of the networks together with their direct and indirect interactions
are presented in Fig. 5a. The following gene products emerged as
hubs (at day one): STAT3 (NM_213659.2), a transcription factor
involved in cytokine signaling; CDKN1A (NM_007669.4), cyclin-
dependent kinase inhibitor 1, which inhibits cyclin-CDK2
(NM_016756.4) or CDK4 (NM_009870.3) and acts as a regulator
of cell cycle; CEBPA (NM_007678.3), a bZIP transcription factor
involved in cytokine (leptin) signaling; Insulin, a well known
hormone associated with carbohydrate and fat metabolism; AP-1,
a transcription factor stimulated by cytokines and growth factors;
Ras homolog, which is involved in cell contraction and
cytoskeleton rearrangement; and MIR124, a microRNA involved
in brain-specific pre-mRNA splicing. Overall, genes associated
with transcription, cell cycle regulation and inflammatory response
appear to occupy prominent positions (hubs) in the network
topology.
In accord with the changes in gene expression pattern, there
were substantial changes in the CNTF-induced networks three
days after CNTF treatment (Fig. 5b). The following gene products
were found as hubs: CCL3 (NM_011337.2) and CCL4
(NM_013652.2), chemokines involved in the activation and
recruitment of polymorphonuclear leukocytes; CCL13, a che-
moattractant induced by IL1b (NM_008361.3) and TNF-a
(NM_013693.2), and a ligand for CCR5 (NM_009917.5); CCR5
and CXCR4 (NM_009911.3), chemokine receptors that act as co-
receptors for HIV entry into cells; TyroBP (NM_011662.2), a
transmembrane signaling receptor with a role in inflammation;
PLCG2 (NM_172285.1) and PLC gamma (NM_021280.3),
phospholipases associated with cell signaling; SYK (NM_
001198977.1), a non-receptor tyrosine kinase involved in B cell
signaling; and TGFBR1 (NM_009370.2), transforming growth
ß receptor 1.
CNTF is an inducer of gliosis in Mu ¨ller cells
CNTF can also act as an inducer of reactive gliosis in the CNS
[41,54]. Intravitreal injection of CNTF in rodents rapidly induces
GFAP, a hallmark of gliosis in the nervous system [43,46].
Virtually every retinal disease is associated with ‘activation’ of
Mu ¨ller cells and reactive gliosis [41,42]; it is possible that CNTF
might be one of the endogenous inducers. Moreover, CNTF is
upregulated in response to retinal degeneration and injury [55,56].
To further establish CNTF as a candidate inducer of gliosis in
the retina, we compared transcripts with increased expression in
CNTF-stimulated Mu ¨ller cells with genes expressed in ‘reactive’
Mu ¨ller cells. Rattner and Nathans [50] previously reported retinal
transcriptional profile changes in two mouse models of retinal
degeneration, the procadherin-knockout (proCAD) strain and
mice with light damage [50]. Using in situ hybridization to localize
some of the upregulated transcripts, they found that many of the
upregulated genes were localized to Mu ¨ller cells. A comparison of
our microarray data with those of Rattner and Nathans [50] is
presented in Table 4. All ten genes upregulated in light-damaged
retina and six genes upregulated in proCAD mutant retina also
showed increases in transcript levels, although the fold-changes
differed. For example, ceruloplasmin (NM_001042611.1) in-
creased , 8-fold in light damaged retinas compared to 2-fold in
CNTF-treated retina. These data show that CNTF-activated
Mu ¨ller cells express several genes, some of which are also induced
in reactive Mu ¨ller cells from proCAD mice or mice with light
damage; thus, suggesting that CNTF is a likely to be an inducer of
gliosis in the retina.
Comparison of gene profile of Mu ¨ller cells with
astrocytes and RPE
Mu ¨ller (glial) cells perform metabolic functions similar to
astrocytes and RPE [41,57]. To determine whether this similarity
is also reflected in the gene expression profiles of these cell types,
we compared the top 2000 highly expressed transcripts from
Mu ¨ller cells and astrocytes (Table S1), using previously published
astrocyte transcriptome data from postnatal day-17 mice [58]. As
shown in Figure 6, 642 genes were common to Mu ¨ller cells and
astrocytes yielding a 32% overlap in transcriptional pattern. In
comparison, Mu ¨ller cells and retinal pigment epithelial cells (RPE)
have 565 genes in common. The RPE transcriptome data were
obtained from a recent publication [59]. There is a 14% overlap
(381 genes) in highly expressed genes among the three different cell
types (Fig. 6a). When compared with transcriptional profiles of
neurons, there was an overlap of 27% (Fig. 6b, 58).
IPA of the 381 genes (common to Mu ¨ller cells, astrocytes and
RPE) showed that the top canonical pathways were concerned
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sis/gluconeogenesis, hypoxia signaling and ubiquinone biosynthe-
sis. This finding is in accord with the known supportive roles of the
three cell types in energy metabolism in the retina [41,57]. The
top biological functions involve protein synthesis, RNA post-
transcriptional modification, and energy production (Fig. 7).
Network analysis of the genes as well as their direct and
indirect interactions (Fig. 7) revealed the following gene products
emerged as hubs: ATP5I (NM_007507.2), mitochondrial ATP
synthase; H
+-transporting, two-sector ATPase; vacuolar H
+-
ATPase; LDHA (NM_001136069.2), lactate dehydrogenase;
YWHAZ (NM_011740.3), an adapter protein implicated in
several signal transduction pathways; and NFkB complex, which
controls transcription and is involved in cellular response to
cytokines. Overall, genes associated with carbohydrate metabo-
Table 3. List of differentially regulated genes in Mu ¨ller cells
three days after CNTF treatment.
Gene
Symbol Gene Name
Fold
Change Type
Spp1 Secreted phosphoprotein 1 15.8 Cytokines
(16, 4)
Ccl3l3 Chemokine (C-C motif) ligand 3-like 3 14.8 -
Pf4 Platelet factor 4 12.4 -
Nampt Nicotinamide phosphoribosyltransferase 4.0 -
Ccl13 Chemokine (C-C motif) ligand 13 3.9 -
Thpo Thrombopoietin -2.0 -
Prl Prolactin -2.1 -
Ifnk Interferon, kappa -2.1 -
Il1f8 Interleukin 1 family, member 8 (eta) -2.3 -
Cybb Cytochrome b-245, beta polypeptide 14.9 Enzymes
(271, 28)
Gpnmb Glycoprotein (transmembrane) nmb 14.0 -
Gatm Glycine amidinotransferase 11.2 -
Ppib Peptidylprolyl isomerase B (cyclophilin B) 10.0 -
Hpgds Hematopoietic prostaglandin D synthase 10.0 -
Fut1 Fucosyltransferase 1 -2.5 -
Bche Butyrylcholinesterase -2.5 -
B3gat2 Beta-1,3-glucuronyltransferase 2 -2.6 -
Gng13 Guanine nucleotide binding protein,
gamma 13
-3.6 -
Gcsh Glycine cleavage system protein H -4.7 -
C3ar1 Complement component 3a receptor 1 20.4 G-proteins
(14, 82)
Emr1 Egf-like module containing, mucin-like 9.2 -
Cxcr4 Chemokine (C-X-C motif) receptor 4 8.1 -
Ccr5 Chemokine (C-C motif) receptor 5 6.5 -
Gpr65 G protein-coupled receptor 65 5.8 -
Olfr703 Olfactory receptor 703 -3.4 -
Olfr619 Olfactory receptor 619 -3.5 -
Olfr921 Olfactory receptor 921 -3.9 -
Olfr777 Olfactory receptor 777 -4.2 -
Olfr153 Olfactory receptor 153 -4.8 -
Grn Granulin 5.2 Growth
Factors
(3, 0)
Gmfb Glia maturation factor, beta 3.2 -
Hgf Hepatocyte growth factor (hepapoietin A) 2.8 -
Clic1 Chloride intracellular channel 1 2.7 Ion
Channels
(6, 0)
Clic4 Chloride intracellular channel 4 2.6 -
Fxyd5 FXYD domain containing ion transport
regul 5
2.6 -
P2rx4 Purinergic receptor P2X, ligand-gated ion
chan, 4
2.2 -
P2rx7 Purinergic receptor P2X, ligand-gated ion
chan, 7
2.0 -
Taf9 TAF9 RNA polymerase II, TATA
box binding protein
8.1 Transc.
Reg.
(80, 20)
Sp100 Protein SP100 nuclear antigen 7.3 -
Tcea1 Transcription elongation factor A (SII), 1 7.1 -
Gene
Symbol Gene Name
Fold
Change Type
Supt4h1 Suppressor of Ty 4 homolog 1
(S. cerevisiae)
5.7 -
Rel V-rel reticuloendotheliosis viral oncogene
homolog
5.6 -
Phb Prohibitin -2.3 -
Gli3 GLI family zinc finger 3 -2.3 -
Erg V-ets erythroblastosis virus E26 oncogene
homolog
-2.4 -
Abra Actin-binding Rho activating protein -2.4 -
Ankz1 Ankyrin repeat and zinc finger domain -2.5 -
Hla-c Major histocompatibility complex,
class I, C
17.0 Transm.
Receptors
(48, 1)
Msr1 Macrophage scavenger receptor 1 12.9 -
Clec7a C-type lectin domain family 7, member A 10.2 -
Fcrl2 Fc receptor-like 2 7.1 -
Tlr7 Toll-like receptor 7 6.9 -
Gfra2 GDNF family receptor alpha 2 -2.0 -
Saa1 Serum amyloid A1 15.4 Tran-
sporters
(101, 11)
M6pr Mannose-6-phosphate receptor
(cation dependent)
6.3 -
Gabarap GABA(A) receptor-associated protein 5.9 -
Mfsd1 Major facilitator superfamily domain
containing 1
5.7 -
Atp6v1e1 ATPase, H+ transporting,
lysosomal 31kDa, V1, E1
5.4 -
Timm9 Translocase of inner mitochondrial
membrane 9
-2.3 -
Atp6ap2 ATPase, H+ transporting,
lysosomal protein 2
2.3 -
Igfbp7 Insulin-like growth factor
binding protein 7
-2.5 -
Apod Apolipoprotein D -2.9 -
Disp1 Dispatched homolog -3.9 -
The table lists the top-five up- and down-regulated genes derived from IPA
analysis. The total number of up- and down –regulated genes in each type is
listed along with the functional types, in column 4.
doi:10.1371/journal.pone.0020326.t003
Table 3. Cont.
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PLoS ONE | www.plosone.org 7 May 2011 | Volume 6 | Issue 5 | e20326Figure 4. Changes in pathways and processes induced by CNTF. The diagram indicates potential biological processes and their inter-
relationships in Mu ¨ller cells at day 1 and day 3 after CNTF treatment. The processes and pathways were generated from IPA analysis.
doi:10.1371/journal.pone.0020326.g004
Figure 5. The most prominently affected gene networks generated by Ingenuity Pathway Analysis. (a) Day 1- Genes in this network are
responsible for cellular development, connective tissue disorder and metabolic disease. (b) Day 3- Genes in this network are responsible for cellular
function and maintenance, molecular transport and inflammatory response. Red color indicates induction, while green represents repression; color
intensity correlates with fold change.
doi:10.1371/journal.pone.0020326.g005
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metabolism appear to occupy prominent positions (hubs) in the
network topology.
Discussion
We report that CNTF induces rapid and extensive changes in the
transcriptional profile of Mu ¨ller (glial) cells in vivo. The activated
genes involve growth factors, cytokines, ion channels, kinases,
phosphatases, and G-protein coupled receptors that are compo-
nents of cellular pathways concerned with cell- to -cell signaling, cell
cycle and inflammation. The widespread genomic response of
Mu ¨ller cells is likely the basis for the numerous effects of CNTF on
the development, differentiation and survival of retinal neurons.
Genes induced by CNTF are reported to carry a CNTF-
response element, 59-TTCC (N 3-5) AA-39 (CNTF-RE) in their 59-
flanking sequence [60]. We observed that a majority of
upregulated genes had one or more (up to 6) CNTF-RE sites in
their 59-flanking sequence (,1 kb). For example, among genes
that are upregulated at least 6-fold (n=51), 45 had the CNTF-RE
on the direct or coding strand, one gene (Tnfaip2: NM_009396.2)
did not have CNTF-RE site and four genes had a CNTF-RE site
on the non-coding strand. Genes that carry the CNTF-RE are
likely to be activated by the direct action of CNTF while genes
without CNTF-RE element could be induced by secondary
mechanisms.
CNTF-mediated photoreceptor neuroprotection
CNTF acts as a neuroprotective agent in many animal models
of retinal degeneration [27–36,61]. One hypothesis postulates that
CNTF acts directly on photoreceptors to promote their survival.
The absence of CNTF receptors on rodent photoreceptors and the
lack of STAT3 phosphorylation in photoreceptors following
CNTF treatment have been advanced as evidence against this
suggestion [38]. Recent studies with LIF (NM_001039537.1), a
close relative of CNTF, show that this cytokine might directly act
on photoreceptors [62]. In transgenic mice with conditional
ablation of the gp130 gene in photoreceptors, LIF was unable to
rescue light-induced photoreceptor degeneration whereas LIF was
able to promote photoreceptor survival in mice with conditional
inactivation of gp130 gene in Mu ¨ller cells [62]. It could be argued
that CNTF might act in a manner analogous to LIF.
A second hypothesis, termed the Mu ¨ller cell hypothesis of
neuroprotection, states that the CNTF effect on photoreceptors is
indirect, and that CNTF mediates its neuroprotective effect by
stimulating Mu ¨ller cells [40–42]. Many lines of evidence support
this hypothesis. CNTF receptors are found on Mu ¨ller cells, and
CNTF treatment rapidly stimulates the JAK-STAT pathway in
Mu ¨ller cells [43–46,63]. Our experimental data clearly show that
several growth factors and cytokines are induced by CNTF in
Mu ¨ller cells. However, none of the previously-tested, photorecep-
tor neuroprotective agents— Basic Fibroblast growth factor, bFGF
(NM_008006.2); Brain-derived neurotrophic factor, BDNF
(NM_001048139.1); Glia-derived neurotrophic factor, GDNF
(NM_010275.2); Pigment epithelium-derived factor, PEDF
(NM_011340.3); Lens epithelium-derived growth factor, LEDGF
(NM_133948.4); Fibroblast growth factor-5, FGF-5 (NM_
Table 4. Comparison of transcript level changes in retinas
from procadherin-knockout (proCAD) and light damaged
mice with Mu ¨ller cells from CNTF-treated mouse retinas.
Fold Change
Gene name
Gene
symbol
proCAD
mutant
Light
damage
CNTF-
treated
CCAT enhancer binding
protein
Cebpd 5.7 19.3 4.26
Ceruloplasmin Cp 0 8.2 2.43
Endothelin 2 Edn2 11.4 12.9 6.71
GFAP Gfap 5 3.8 5.41
Lipocalin 2 Lcn2 0 17.9 2.63
Oncostatin M receptor Osmr 3.4 8.2 3.5
S100 protein S100a6 0 5.5 3.51
Serpin a3n Serpin a3n 2.1 5.7 5.02
SOCS-3 Socs3 2.9 13.5 3.6
Soluble galactose binding
protein
Lgals3 0 5.9 6.04
The pro-CAD and light damage data are from ref. 50.
doi:10.1371/journal.pone.0020326.t004
Figure 6. Overlapping genes in transcription profiles from Mu ¨ller cells, astrocytes and retinal pigment epithelium (RPE). Intensity
signals for the top 2000 probes were used to generate sets of overlapping genes. The astrocyte and RPE transcriptome data are derived from
published studies (56,57). Mu ¨ller cell data represent signals from cells not exposed to CNTF. (a) The diagram shows that 381 transcripts were common
to the three cell types, while 642 were shared between Mu ¨ller cells and astrocytes, 565 between Mu ¨ller cells and the RPE, and 604 between astrocytes
and RPE. (b) Diagram showing overlap of transcripts among astrocytes, Muller cells and neurons. The neuron transcriptome data was obtained from a
published study (56).
doi:10.1371/journal.pone.0020326.g006
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Interleukin 1ß, IL1ß; Rod-derived cone survival factor, RDCVF
(NM_145598.2); Insulin-like growth factor II, IGFII (NM_0011
22736.1); Colony stimulating factor, CSF-1 (NM_001113529.1);
and LIF are induced in Mu ¨ller cells by CNTF [64–72]. This
observation may argue against the Mu ¨ller cell hypothesis of
neuroprotection. It is, nevertheless, possible that other growth
factors or cytokines induced by CNTF (Tables S1, S2) are involved
in photoreceptor neuroprotection.
Two other mechanisms have been implicated in CNTF-
mediated neuronal survival. One mechanism states that CNTF
might enhance synthesis or distribution of glutamate transporters,
which could improve glutamate handling resulting in less
excitotoxic damage to neurons. In the rat striatum, CNTF has
been reported to increase glutamate uptake by redistribution of
glutamate transporters [39]. Although we have not examined
glutamate transporter distribution, our data does not reveal an
increase in glutamate transporter transcripts in response to CNTF
(Table S1). Another mechanism involves CNTF-induced meta-
bolic changes that enhance resistance to severe metabolic insults
[40]. In CNTF-treated Mu ¨ller cells, there were no changes in the
expression glucose or lactate transporters (Table S1, S2).
Figure 7. Gene networks common to Mu ¨ller cells, astrocytes and RPE. (a) Most significant canonical pathways; (b) Most significant biological
functions for the same list of genes; and (c) Genes in this network are responsible mitochondrial function and metabolism.
doi:10.1371/journal.pone.0020326.g007
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retinal ganglion cells after axotomy [25,26]. The mechanism
underlying this neuroprotective effect is not known. CNTF could
directly act on retinal ganglion cells (RGCs) or it could act on
Mu ¨ller cells to trigger production on RGC survival factors
[73–82]. Alternatively, CNTF injection could lead to production
of Oncomodulin or another RGC survival factor from retinal
microglia/macrophages [83].
One limitation of the present study is that gene expression
profiling could be potentially affected by post-mortem changes in
gene transcription during tissue removal, cell sorting and RNA
preparation. Independent in vivo measurements of gene expres-
sion will be needed to understand in situ CNTF response. Another
concern is that we cannot completely rule out the possibility that
there might be a few GFP-positive astrocytes among flow-sorted
cells from GFAP-GFP transgenic retinas. But the majority of cells
in the flow-sorted population are likely to be Mu ¨ller cells with
,1% contribution from astrocytes. The density of Mu ¨ller cells in
the mouse retina is ,12,000 per mm
2 [84]. The density of
astrocytes in the mammalian retina is ,600 per mm
2 [85], which
is 5% of Mu ¨ller cells. If 10% GFP-positive astrocytes remain in
one-month old, GFAP-EGFP mouse retina, astrocyte contamina-
tion in flow-sorted cells would amount to ,1%. Therefore, the
gene expression profile we have studied is largely representative of
transcription profile changes in Mu ¨ller cells rather than astrocytes.
CNTF is an inducer of reactive gliosis in Mu ¨ller cells
A variety of agents including growth factors, cytokines,
glutamate and purines have been suggested as inducers of reactive
gliosis in the CNS [86]. In the retina, cytokines belonging to the
IL-6 family as well as bFGF have been shown to induce gliosis (as
determined by GFAP induction) in Mu ¨ller cells [43,46,87]. We
found that several genes that are induced by CNTF in quiescent
Mu ¨ller cells are also upregulated in gliotic Mu ¨ller cells from
inherited and experimentally-induced retinal degenerations [49].
These data strongly suggest that CNTF can act as an inducer of
gliosis in the retina. This inference is supported by the finding that
CNTF is upregulated in response to retinal degeneration and
injury that results in Mu ¨ller cell gliosis [55,56].
Mu ¨ller cells, astrocytes and RPE serve support functions
It is generally accepted that Mu ¨ller cells are functionally similar
to astrocytes [42], although they are generated through different
lineages [41]. Whereas Mu ¨ller cells are derived from a retinal
progenitor common to rods, bipolar cells and Mu ¨ller cells [88],
retinal astrocytes are generated from an oligodendrocyte/astrocyte
precursor [89]. A comparison of transcript profiles of Mu ¨ller cells
and astrocytes shows that of the 2000 highly expressed genes, 642
genes (32%) were common to Mu ¨ller cells and astrocytes. A closer
examination shows that for many genes, the level of expression,
however, is different between the two cell types, consistent with the
previous transcriptome data on Mu ¨ller cells [90]. In addition,
there is a significant overlap (,14%) among genes expressed by
Mu ¨ller cells, astrocytes and RPE. Muller cells and astrocytes are
believed to have analogous functions in the CNS [41]. The RPE
has been considered a separate entity. The present study, however,
suggests that the RPE shares some metabolic pathways with
Muller cells and astrocytes; it appears that Mu ¨ller cells, astrocytes
and RPE have evolved to support the metabolic needs of the
neural retina.
In summary, the present study shows that (i) CNTF induces
rapid and extensive changes in the transcriptional profile of Mu ¨ller
(glial) cells; (ii) that several genes induced by CNTF in normal
Mu ¨ller cells are also upregulated in gliotic Mu ¨ller cells from
inherited and experimentally-induced retinal degenerations, which
suggests that CNTF is an inducer of gliosis in the retina; and (iii)
the transcript profiles of Mu ¨ller cells and astrocytes are similar
although they are derived from distinct cell lineages. Finally,
CNTF induces networks in which genes associated with
transcription, cell cycle regulation and inflammatory response
appear to occupy prominent positions (hubs) in the network
topology.
Materials and Methods
Mice
All mice were used in accordance with the approved
Northwestern University Institutional Animal Care and Use
Committee (IACUC) protocol, 2008-1398 that specifically ap-
proved this study. Northwestern University Animal Welfare
assurance is on file with the Office of Laboratory Animal Welfare
(A3283-01).
Purifying GFP
+-Mu ¨ller cells by FACS
We previously described a transgenic mouse line, mgfap-egfp,i n
which GFP is expressed only in retinal Mu ¨ller cells [48]. We used
the transgenic mice to purify Mu ¨ller cells based on GFP-
expression. CNTF or PBS was intravitreally injected into
anesthetized, transgenic mice (one month old) as described earlier
[42]. We used one eye for CNTF treatment and the fellow eye as
PBS control. In order to ensure CNTF action, we routinely
selected a few injected animals and examined retinal sections for
GFAP expression in Mu ¨ller cells [48]. Similarly, we also examined
PBS injected eyes. We always found GFAP expression in Mu ¨ller
cells in the CNTF- but not PBS-injected eyes
Retinas from mgfap-egfp transgenic mice were treated with
papain for 30 min, and dissociated into a single cell suspension.
The cells were filtered through a 70 mm nytex mesh to get rid of
cell clumps. GFP
+-cells were enriched by FACS (MoFlo; Dako,
Carpintaria, CA) at Northwestern Flow Cytometry Core facility.
Microarray data procurement and analysis
Microarray analysis was carried out as described previously
[49]. We performed total RNA extraction (TRIZOL; Invitrogen,
Carlsbad, CA) from (,50–100,000) flow-sorted cells, and
confirmed the integrity of RNA with a bioanalyzer (model 2100;
Agilent Technologies, Palo Alto, CA). All RNA samples had
average RIN of 8.6660.79 (12 samples). We synthesized, labeled,
and hybridized cRNA onto arrays at Genome Explorations
(Memphis, TN) according to standard Affymetrix methods,
previously described [49]. We performed transcriptional profiling
using mouse Affymetrix chips (mouse Expression Array 230 2.0).
The experiments were done in biological triplicates and micro-
array data were analyzed as reported previously [49].
For Day 1, four biological replicates were used on Affymetrix
GeneChip Mouse Genome MOE430 2.0. For Day 3 we also used
4 biological replicates on Affymetrix Exon Chip MoEx ST1.v1.
Raw data were normalized and analyzed using GeneSpring GX
11.0.2 software (Silicon Genetics, Redwood City, CA). For
normalization we used Robust Multichip Average (RMA) method.
We performed background correction followed by quantile
normalization and used the average mean for summarization.
We performed a one-way ANOVA (a simple t-test for this simple
situation) for comparison between CNTF and PBS at Day 1 and
Day 3. We used an un-corrected p-value #0.1 which led to a total
of 5336 probes for Day 1 and 6777 for Day 3. These two sets were
subjected to a 2-fold change filter value between CNTF and PBS
at Day 1 and Day 3. This resulted in a set of 1261 for Day 1 and
CNTF Effects on Retinal Mu ¨ller (Glia) Cells
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obtained 1063 independent genes while for Day 3 the list
contained 1530 genes.
RNA preparation and Real-Time PCR Analysis (qPCR)
qPCR analysis of FACS-purified Mu ¨ller cells was carried out to
validate the findings from the microarray data [23]. We performed
primer design, one-step RT-PCR reaction, and qPCR analysis as
previously described [49]. Primers were designed using the
PrimerQuest
SM IDT-DNA site. To eliminate genomic contami-
nation, we treated total RNA with RQ1 RNase-free DNase
(Promega, Madison, WI). We performed qPCR reaction in a
thermocycler (iCycler; Bio-Rad, Richmond, CA), using the
reagents in the SYBR Green iQ Real-time PCR kit; (Bio-Rad,
Richmond, CA). To determine the relative change in gene
expression, we used the system software to compare the number of
cycles (Ct) needed to reach the midpoint of the linear phase. All
observations were normalized to the housekeeping gene Gapdh.W e
used actin, hsp90 or hprt1 as additional controls along with Gapdh.
The qPCR data are from 3-6 biological replicates.
Supporting Information
Table S1 Supporting table.
(DOC)
Table S2 Supporting table.
(DOC
Acknowledgments
We thank members of the Sarthy and Swaroop labs for assistance and
discussions. The authors have no commercial interest in the subject of the
manuscript or in entities discussed in the manuscript.
Author Contributions
Conceived and designed the experiments: WX VPS AS. Performed the
experiments: WX VJD MB. Analyzed the data: RIC VPS. Contributed
reagents/materials/analysis tools: WX RIC VJD MB AS VPS. Wrote the
paper: VPS AS.
References
1. Nicola NA (1994) Guidebook to cytokines and their receptors. Oxford, UK:
Oxford University Press. 284 p.
2. Ip N, Yancopoulos GD (1996) The neurotrophins and CNTF: Two families of
collaborative neurotrophic factors. Ann Rev Neurosci 19: 491–515.
3. Levy DE, Darnell JE (2002) STATS: Transcriptional control and biological
impact. Nature Rev Mol Cell Biol 3: 651–662.
4. Nishimune H, Vasseur S, Wiese S, Birling MC, Holtmann B, et al. (2000) Reg-2
is a motoneuron neurotrophic factor and a signalling intermediate in the CNTF
survival pathway. Nature Cell Biol 2: 906–914.
5. Rane SG, Reddy EP (2000) Janus kinases: components of multiple signaling
pathways. Oncogene 19: 5662–5679.
6. Servidei T, Aoki Y, Lewis SE, Symes A, Fink JS, et al. (1998) Coordinate
regulation of STAT signaling and c-fos expression by the tyrosine phosphatase
SHP-2. J Biol Chem 273: 6233–6241.
7. Yokogami KM, Wakisaka S, Avruch J, Reeves SA (2000) Serine phosphory-
lation and maximal activation of STAT3 during CNTF signaling is mediated by
the rapamycin target mTOR. Current Biology 10: 47–50.
8. Alonzi T, Middleton G, Wyatt S, Buchman V, Betz UAK, et al. (2001) Role of
STAT3 and Pl 3-Kinase/Akt in mediating the survival actions of cytokines on
sensory neurons. Mol Cell Neurosci 18: 270–282.
9. Boulton TG, Stahl N, Yancopoulos GD (1994) Ciliary neurotrophic factor/
leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines
induces tyrosine phosphorylation of a common set of proteins overlapping those
induced by other cytokines and growth factors. J Biol Chem 269: 11648–11655.
10. Oh H, Fujio Y, Kunisada K, Hirota H, Matsui H, et al. (1998) Activation of
phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B
and p70 S6 kinase phosphorylation in cardiac myocytes. J Biol Chem 273:
9703–9710.
11. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, et al.
(2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation.
Biochem J 374: 1–20.
12. Gallagher D, Gutierrez H, Gavalda N, O’Keefe G, Hay R, et al. (2007) Nuclear
factor-kB activation via tyrosine phosphorylation of inhibitor kB-a is crucial for
ciliary neurotrophic factor-promoted neurite growth from developing neurons.
J Neurosci 27: 9664–966.
13. Hagg T, Varon S (1993) Ciliary neurotrophic factor prevents degeneration of
adultratsubstantianigradopaminergicneuronsinvivo.ProcNatlAcadSciUSA
90: 6315–631.
14. Lo AC, Li L, Oppenheim RW, Prevette D, Houenou LJ (1995) Ciliary
neurotrophic factor promotes the survival of spinal sensory neurons following
axotomy but not during the period of programmed cell death. Exp Neurol 134:
49–55.
15. MacLennan AJ, Vinson EN, Marks L, McLaurin DL, Pfeifer M, et al. (1996)
Immunohistochemical localization of ciliary neurotrophic factor receptor alpha
expression in the rat nervous system. J Neurosci 16: 621–630.
16. Sendtner M, Kreutzberg GW, Thoenen H (1990) Ciliary neurotrophic factor
prevents the degeneration of motor neurons after axotomy. Nature 345:
440–441.
17. Sendtner M, Schmalbruch H, Stockli KA, Carroll P, Kreutzberg GW, et al.
(1992) Ciliary neurotrophic factor prevents degeneration of motor neurons in
mouse mutant progressive motor neuronopathy. Nature 358: 502–504.
18. Deverman BJ, Patterson PH (2009) Cytokines and CNS development. Neuron
64: 61–78.
19. Linker RA, Ma ¨urer M, Gaupp S, Martini R, Holtmann B, et al. (2002) CNTF is
a major protective factor in demyelinating CNS disease: a neurotrophic cytokine
as modulator in neuroinflammation. Nature Med 8: 620–624.
20. Lambert PD, Anderson KD, Sleeman MW, Wong V, Tan J, et al. (2001) Ciliary
neurotrophic factor activates leptin-like pathways and reduces body fat, without
cachexia or rebound weight gain, even in leptin-resistant obesity. Proc Natl Acad
Sci U S A 98: 4652–4657.
21. Rhee KD, Yang XJ (2010) Function and mechanism of CNTF/LIF signaling in
retinogenesis. Adv Exp Med Biol 664: 647–654.
22. Kirsch M, Lee MY, Meyer V, Wiese A, Hofmann HD (1997) Evidence for
multiple, local functions of ciliary neurotrophic factor (CNTF) in retinal
development: expression of CNTF and its receptors and in vitro effects on
targets. J Neurochem 68: 979–990.
23. Ezzedine ZD, Yang X, DeChiara T, Yancopoulos G, Cepko CL (1997)
Postmitotic cells fated to become rod photoreceptors can be respecified by
CNTF treatment. Development 124: 1055–67.
24. Rhee KD, Goureau O, Chen S, Yang XJ (2004) Cytokine-induced activation of
signal transducer and activator of transcription in photoreceptor precursors
regulates rod differentiation in the developing mouse retina. J Neurochem 224:
9779–88.
25. Meyer-Franke A, Kaplan MR, Pfrieger FW, Barres BA (1995) Characterization
of the signaling interactions that promote the survival and growth of developing
retinal ganglion cells in culture. Neuron 15: 805–819.
26. Cui Q, Lu Q, So KF, Yip HK (1999) CNTF, not other trophic factors, promotes
axonal regeneration of axotomized retinal ganglion cells in adult hamsters.
Invest Ophthalmol Vis Sci 40: 760–766.
27. LaVail MM, Unoki K, Yasumura D, Matthes MT, Yancopoulos GD, et al.
(1992) Multiple growth factors, cytokines, and neurotrophins rescue photore-
ceptors from the damaging effects of constant light. Proc Natl Acad Sci U S A
89: 11249–11253.
28. Cayouette M, Gravel C (1997) Adenovirus-mediated gene transfer of ciliary
neurotrophic factor can prevent photoreceptor degeneration in the retinal
degeneration (rd) mouse. Human Gene Ther 8: 423–430.
29. LaVail MM, Yasumura D, Matthes MT, Lau-Villacorta C, Unoki K, et al.
(1998) Protection of mouse photoreceptors by survival factors in retinal
degenerations. Invest Ophthalmol Vis Sci 39: 592–602.
30. Liang FQ, Dejneka NS, Cohen DR, Krasnoperova NV, Lem J, et al. (2001)
AAV-mediated delivery of ciliary neurotrophic factor prolongs photoreceptor
survival in the rhodopsin knockout mouse. Mol Ther 3: 241–248.
31. Bok D, Yasumura D, Matthes MT, Duncan JL, Chappelow AV, et al. (2002)
Effects of adeno-associated virus-vectored ciliary neurotrophic factor on retinal
structure and function in mice with a P216L rds/peripherin mutation. Exp Eye
Res 74: 719–735.
32. Liang FQ, Aleman TS, Dejneka NS, Dudus L, Fisher KJ, et al. (2001) Long-
term protection of retinal structure but not function using RAAV CNTF in
animal models of retinitis pigmentosa. Mol Ther 4: 461–472.
33. Wen R, Song Y, Kjellstrom S, Tanikawa A, Liu Y, et al. (2006) Regulation of
rod phototransduction machinery by ciliary neurotrophic factor. J Neurosci 26:
13523–13530.
34. Tao W, Wen R, Goddard MB, Sherman SD, O’Rourke PJ, et al. (2002)
Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration
in animal models of retinitis pigmentosa. Invest Ophthalmol Vis Sci 43:
3292–3298.
CNTF Effects on Retinal Mu ¨ller (Glia) Cells
PLoS ONE | www.plosone.org 12 May 2011 | Volume 6 | Issue 5 | e2032635. Chong NH, Alexander RA, Waters L, Barnett KC, Bird AC, et al. (1999)
Repeated injections of a ciliary neurotrophic factor analogue leading to long-
term photoreceptor survival in hereditary retinal degeneration. Invest Ophthal-
mol Vis Sci 40: 1298–1305.
36. Schlichtenbrede FC, MacNeil A, Bainbridge JW, Tschemutter M, Thrasher AJ,
et al. (2003) Intraocular gene delivery of ciliary neurotrophic factor results in
significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2
model of retinal degeneration. Gene Ther 10: 523–527.
37. Sieving PA, Caruso RC, Tao W, Coleman HR, Thompson DJ, et al. (2006)
Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial
of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad
Sci U S A 103: 3896–3901.
38. Zack DJ (2000) Neurotrophic rescue of photoreceptors: Are Mu ¨ller cells the
mediators of survival? Neuron 26: 285–286.
39. Escartin C, Brouillet E, Gubbellini P, Trioulier Y, Jacquard C, et al. (2006)
Ciliary neurotrophic factor activates astrocytes, redistributes their glutamate
transporters GLAST and GLT-1 to raft microdomains, and improves glutamate
handling in vivo. J Neurosci 26: 5978–5989.
40. Escartin C, Pierre K, Colin A, Brouillet E, Delzescaux T, et al. (2007) Activation
of astrocytes by CNTF induces metabolic plasticity and increases resistance to
metabolic insults. J Neurosci 27: 7094–7104.
41. Sarthy V, Ripps H (2001) The Retinal Mu ¨ller Cell. New York, NY: Structure
and Function. Kluwer Academic/Plenum Press. 278 p.
42. Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, et al. (2007)
Mu ¨ller cells in the healthy and diseased retina. Prog Ret Eye Res 25: 397–
424.
43. Peterson WM, Wang Q, Tzekova R, Wiegand SJ (2000) Ciliary neurotrophic
factor and stress stimuli activate the Jak-STAT pathway in retinal neurons and
glia. J Neurosci 20: 4081–4090.
44. Wahlin KJ, Campochiaro PA, Zack DJ, Adler R (2000) Neurotrophic factors
cause activation of intracellular signaling pathways in Mu ¨ller cells and other cells
of the inner retina, but not photoreceptors. Invest Ophthalmol Vis Sci 41:
927–936.
45. Wahlin KJ, Adler R, Zack DJ, Campochiaro PA (2001) Neurotrophic signaling
in normal and degenerating rodent retinas. Exp Eye Res 73: 693–701.
46. Wang Y, Smith SB, Ogilvie JM, McCool DJ, Sarthy V (2002) Ciliary
neurotrophic factor induces glial fibrillary acidic protein in retinal Mu ¨ller cells
through the JAK/STAT signal transduction pathway. Current Eye Res 24:
305–312.
47. Jeon C-J, Strettoi E, Masland RH (1998) The major cell populations of the
mouse retina. J Neurosci 18: 8936–8946.
48. Kuzmanovic M, Dudley VJ, Sarthy VP (2003) GFAP promoter drives Mu ¨ller
cell-specific expression in transgenic mice. Invest Ophthalmol Vis Sci 44:
3606–3613.
49. Akimoto M, Cheng H, Zhu D, Brzezninski JA, Khanna R, et al. (2006)
Targeting of GFP to newborn rods by Nrl promoter and temporal expression
profiling of flow-sorted photoreceptors. Proc Natl Acad Sci U S A 103:
3890–3895.
50. Rattner A, Nathans J (2005) The genomic response to retinal disease and injury:
Evidence for endothelin signaling from photoreceptors to glia. J Neurosci 25:
4540–4549.
51. Park KK, Hu Y, Muhling J, Pollett MA, Dallimore EJ, et al. (2009) Cytokine-
induced SOCS expression is inhibited by cAMP analogue: Impact on
regeneration in injured retina. Mol Cell Neurosci 41: 313–324.
52. Biber K, de Jong EK, van Weering HRJ, Boddeke HWGM (2006) Chemokines
and their receptors in central nervous system disease. Curr Drug Targets 7:
29–46.
53. Rose AA, Grosset A-A, Dong Z, Russo C, Macdonald PA, et al. (2010)
Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of
Recurrence and a Novel Therapeutic Target in Breast Cancer. Clinical Cancer
Research 16: 2147–2156.
54. Winter CG, Saotome Y, Levison SW, Hirsh D (1995) A role for ciliary
neurotrophic factor as an inducer of reactive gliosis, the glial response to central
nervous system injury. Proc Natl Acad Sci U S A 92: 5865–5869.
55. Wen R, Song Y, Cheng T, Matthes D, Yasumura D, et al. (1995) Injury induced
upregulation of bFGF and CNTF mRNAs in the rat retina. J Neurosci 15:
7377–7485.
56. Walsh N, Valter K, Stone J (2001) Cellular and subcellular patterns of
expression of bFGF and CNTF in the normal and light stressed adult rat retina.
Exp Eye Res 72: 495–501.
57. Strauss O (2005) The retinal pigment epithelium in visual function. Physiol Rev
85: 845–881.
58. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, et al. (2008) A
transcriptome database for astrocytes, neurons, and oligodendrocytes: a new
resource for understanding brain development and function. J Neurosci 28:
264–278.
59. Strunnikova NV, Maminishkis A, Barb JJ, Wang F, Zhi C, et al. (2010)
Transcriptome analysis and molecular signature of human retinal pigment
epithelium. Human Mol Genet 19: 2468–2486.
60. Segal RA, Greenberg ME (1996) Intracellular signaling pathways activated by
neurotrophic factors. Ann Rev Neurosci 19: 463–89.
61. Bramall AN, Wright AF, Jacobson SG, McInnes RR (2010) The genomic,
biochemical, and cellular responses of the retina in inherited photoreceptor
degenerations and prospects for the treatment of these disorders. Ann Rev
Neurosci 33: 441–72.
62. Ueki Y, Le Y-Z, Chollangi S, Muller W, Ash JD (2009) Preconditioning-induced
protection of photoreceptors requires activation of the signal-transducing
receptor gp130 in photoreceptors. Proc Natl Acad Sci U S A 106: 21389–
21394.
63. Walsh N, Valter K, Stone J (2001) Cellular and subcellular patterns of
expression of bFGF and CNTF in the normal and light stressed adult rat retina.
Exp Eye Res 72: 495–501.
64. Faktorovich EG, Steinberg RH, Yasumura D, Matthes MT, LaVail MM (1990)
Photoreceptor degeneration in inherited retinal dystrophy delayed by basic
fibroblast growth factor. Nature 347: 83–86.
65. Frasson M, Picaud S, Leveillard T, Simonutti M, Mohand-Said S, et al. (1999)
Glial cell line-derived neurotrophic factor induces histologic and functional
protection of rod photoreceptors in the rd/rd mouse. Invest Ophthalmol Vis Sci
40: 2724–2734.
66. Cayouette M, Smith SB, Becerra SP, Gravel C (1999) Pigment epithelium-
derived factor delays the death of photoreceptors in mouse models of inherited
retinal degenerations. Neurobiol Dis 6: 523–532.
67. Lau D, McGee LH, Zhou S, Rendahl KG, Manning WC, et al. (2000) Retinal
degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2.
Invest Ophthalmol Vis Sci 41: 3622–3633.
68. Ogilvie JM, Speck JD, Lett JM (2000) Growth factors in combination, but not
individually, rescue rd1 mouse photoreceptors in organ culture. Exp Neurol 161:
676–685.
69. Machida S, Chaudhry P, Shinohara T, Singh DP, Reddy VN, et al. (2001) Lens
epithelium-derived growth factor promotes photoreceptor survival in light-
damaged and RCS rats. Invest Ophthalmol Vis Sci 42: 1087–
1095.
70. Green ES, Rendahl KG, Zhou S, Ladner M, Coyne M, et al. (2001) Two animal
models of retinal degeneration are rescued by recombinant adeno-associated
virus-mediated production of FGF-5 and FGF-18. Mol Ther 3: 507–
515.
71. Whiteley SJ, Klassen H, Coffey PJ, Young MJ (2001) Photoreceptor rescue after
low-dose intravitreal IL-1beta injection in the RCS rat. Exp Eye Res 73:
557–568.
72. Leveillard T, Mohand-Said S, Lorentz O, Hicks D, Fintz A, et al. (2004)
Identification and characterization of rod-derived cone viability factor. Nat
Genet 36: 755–759.
73. Mey J, Thanos S (1993) Intravitreal injections of neurotrophic factors support
the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res
602: 304–317.
74. Di Polo A, Aigner LJ, Dunn RJ, Bray GM, Aguayo AJ (1998) Prolonged delivery
of brain-derived neurotrophic factor by adenovirus-infected Mu ¨ller cells
temporarily rescues injured retinal ganglion cells. Proc Natl Acad Sci U S A
95: 3978–3983.
75. Chun M-H, Ju W-K, Kim K-Y, Lee M-Y, Hofmann H-D, et al. (2000)
Upregulation of ciliary neurotrophic factor in reactive Mu ¨ller cells in the rat
retina following optic nerve transection. Brain Res 868: 358–362.
76. Cui Qi, Harvey AR (2000) CNTF promotes the regrowth of retinal ganglion cell
axons into murine peripheral nerve grafts. Neuroreport 11: 3999–4002.
77. Martin KR, Quigley HA, Zack DJ, Levkovitch-Verbin H, Kielczewski J, et al.
(2003) Gene therapy with brain-derived neurotrophic factor as a protection:
retinal ganglion cells in rat glaucoma model. Invest Ophthalmol Vis Sci 44:
4357–4365.
78. Leaver SG, Cui Q, Plant GW, Arulpragasam A, Hisheh S, et al. (2006) AAV-
mediated expression of CNTF promotes long-term survival and regeneration of
adult rat retinal ganglion cells. Gene Ther 13: 1328–1341.
79. Pease ME, Zack DJ, Berlinicke C, Bloom K, Cone F, et al. (2009) Effect of
CNTF on retinal ganglion cell survival in experimental glaucoma. Invest
Ophthalmol Vis Sci 50: 2194–2200.
80. Leibinger MA, Mu ¨ller A, Andreadaki A, Hauk TJ, Kirsch M, et al. (2009)
Neuroprotective and axon growth-promoting effects following inflammatory
stimulation on mature retinal ganglion cells in mice depend on Ciliary
neurotrophic factor and Leukemia inhibitory factor. J Neurosci 29:
14334–14341.
81. Mu ¨ller A, Hauk TG, Leibinger M, Marienfeld R, Fischer D (2009) Exogenous
CNTF stimulates axon regeneration of retinal ganglion cells partially via
endogenous CNTF. Mol Cell Neurosci 41: 233–246.
82. Bai Y, Shi Z, Zhuo Y, Liu J, Malakhov A, et al. (2010) In Glaucoma the
upregulated truncated TrkC.T1 receptor isoform in glia causes increased TNF-a
production, leading to retinal ganglion cell death. Invest Ophthalmol Vis Sci 51:
6639–6651.
83. Yi Y, Henzl MT, Lorber B, Nakazawa T, Thomas TT, et al. (2006)
Oncomodulin is a macrophage-derived signal for axon regeneration in retinal
ganglion cells. Nature Neurosci 9: 843–852.
84. Drager U, Edwards DL, Barnstable CJ (1984) Antibodies against filamentous
components in discrete cell types of the mouse retina. J Neurosci 8: 2025–
2042.
85. Schnitzer J (1988) Astrocytes in mammalian retina. Prog Ret Res 7: 209–231.
86. Sofroniew MV (2009) Molecular dissection of reactive astrogliosis and glial scar
formation. Trends Neurosci 32: 638–647.
CNTF Effects on Retinal Mu ¨ller (Glia) Cells
PLoS ONE | www.plosone.org 13 May 2011 | Volume 6 | Issue 5 | e2032687. Lewis GP, Erickson PA, Guerin CJ, Anderson DH, Fisher SK (1992) Basic
fibroblast growth factor: a potential regulator of proliferation and intermediate
filament expression in the retina. J Neurosci 12: 3968–3978.
88. Turner DL, Cepko CL (1987) A common progenitor for neurons and glia
persists in rat retina late in development. Nature 328: 131–136.
89. Rowitch DH, Kriegstein AR (2010) Developmental genetics of vertebrate glial-
cell specification. Nature 468: 214–222.
90. Roesch K, Jadhav AP, Trimarchi JM, et al. (2008) The transcriptome of retinal
Mu ¨ller glial cells. J Comp Neurol 509: 225–238.
CNTF Effects on Retinal Mu ¨ller (Glia) Cells
PLoS ONE | www.plosone.org 14 May 2011 | Volume 6 | Issue 5 | e20326